1. Home
  2. SILO vs UPXI Comparison

SILO vs UPXI Comparison

Compare SILO & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • UPXI
  • Stock Information
  • Founded
  • SILO 2010
  • UPXI 2018
  • Country
  • SILO United States
  • UPXI United States
  • Employees
  • SILO N/A
  • UPXI N/A
  • Industry
  • SILO Apparel
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • SILO Consumer Discretionary
  • UPXI Health Care
  • Exchange
  • SILO Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • SILO 4.5M
  • UPXI 356.9M
  • IPO Year
  • SILO N/A
  • UPXI 2021
  • Fundamental
  • Price
  • SILO $0.60
  • UPXI $6.05
  • Analyst Decision
  • SILO
  • UPXI
  • Analyst Count
  • SILO 0
  • UPXI 0
  • Target Price
  • SILO N/A
  • UPXI N/A
  • AVG Volume (30 Days)
  • SILO 318.6K
  • UPXI 4.7M
  • Earning Date
  • SILO 08-12-2025
  • UPXI 05-16-2025
  • Dividend Yield
  • SILO N/A
  • UPXI N/A
  • EPS Growth
  • SILO N/A
  • UPXI N/A
  • EPS
  • SILO N/A
  • UPXI N/A
  • Revenue
  • SILO $72,102.00
  • UPXI $16,562,327.00
  • Revenue This Year
  • SILO $1.86
  • UPXI $299.03
  • Revenue Next Year
  • SILO N/A
  • UPXI N/A
  • P/E Ratio
  • SILO N/A
  • UPXI N/A
  • Revenue Growth
  • SILO N/A
  • UPXI 1378.83
  • 52 Week Low
  • SILO $0.41
  • UPXI $1.90
  • 52 Week High
  • SILO $4.50
  • UPXI $22.57
  • Technical
  • Relative Strength Index (RSI)
  • SILO 46.08
  • UPXI 44.83
  • Support Level
  • SILO $0.60
  • UPXI $2.73
  • Resistance Level
  • SILO $0.69
  • UPXI $3.47
  • Average True Range (ATR)
  • SILO 0.04
  • UPXI 0.69
  • MACD
  • SILO 0.00
  • UPXI 0.14
  • Stochastic Oscillator
  • SILO 32.14
  • UPXI 36.97

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.

Share on Social Networks: